UNCY Stock Analysis: Buy, Sell, or Hold?
UNCY - Unicycive Therapeutics, Inc. Common Stock
$5.22
0.13 (2.55%)
▲
5d:
-3.87%
30d:
-32.12%
90d:
-21.15%
HOLD
MODERATE Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 13, 2026
28d
Get Alerted When UNCY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: UNCY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: UNCY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.93
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.93
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 1.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: UNCY is currently trading at $5.22, which is considered oversold relative to its 30-day fair value range of $5.58 to $7.75. The stock's valuation (Forward PE: 1.0) is in line with its historical norms (1.1). Remarkably, the market is currently pricing in an annual earnings decline of 1.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, UNCY is in a uptrend. The price is currently testing key support at $6.65. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: UNCY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $38.59 (+639.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, UNCY is in a uptrend. The price is currently testing key support at $6.65. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: UNCY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $38.59 (+639.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.58 -
$7.75
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 639.3% below Wall St target ($38.59)
Trading Range Analysis
30-Day Trading Range
$5.58 -
$7.75
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$6.65
Resistance Level
$8.02
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.01
Wall Street Target
$38.59
(+639.3%)
Valuation Discount vs History
-1.7% cheaper
PE vs Historical
1.0 vs 1.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.7%
(market-implied from PE analysis)
1-Year Target
$5.13
(-2%)
2-Year Target
$5.04
(-3%)
3-Year Target
$4.96
(-5%)
3-Yr Target (if PE normalizes)
(PE: 1→1)
$5.38
(+3%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 1.0 to 1.1
Stabilization Target:
$5.66
(+8.4%)
PE Expansion Potential:
+8.4%
Share & Embed Analysis
Last updated: July 14, 2026 7:03 PM ET
Data refreshes hourly during market hours. Next update: 8:03 PM
Data refreshes hourly during market hours. Next update: 8:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UNCY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$277 | 58 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 46 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$124 | 58 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$99 | 45 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
